205 related articles for article (PubMed ID: 15200421)
21. Effects of inorganic iron and myoglobin on in vitro proximal tubular lipid peroxidation and cytotoxicity.
Zager RA; Foerder CA
J Clin Invest; 1992 Mar; 89(3):989-95. PubMed ID: 1311724
[TBL] [Abstract][Full Text] [Related]
22. Parenteral iron compounds sensitize mice to injury-initiated TNF-alpha mRNA production and TNF-alpha release.
Zager RA; Johnson AC; Hanson SY; Lund S
Am J Physiol Renal Physiol; 2005 Feb; 288(2):F290-7. PubMed ID: 15494544
[TBL] [Abstract][Full Text] [Related]
23. Parenteral iron use in the management of anemia in end-stage renal disease patients.
Bailie GR; Johnson CA; Mason NA
Am J Kidney Dis; 2000 Jan; 35(1):1-12. PubMed ID: 10620537
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin II induces renal oxidant stress in vivo and heme oxygenase-1 in vivo and in vitro.
Haugen EN; Croatt AJ; Nath KA
Kidney Int; 2000 Jul; 58(1):144-52. PubMed ID: 10886559
[TBL] [Abstract][Full Text] [Related]
25. Haptoglobin attenuates hemoglobin-induced heme oxygenase-1 in renal proximal tubule cells and kidneys of a mouse model of sickle cell disease.
Chintagari NR; Nguyen J; Belcher JD; Vercellotti GM; Alayash AI
Blood Cells Mol Dis; 2015 Mar; 54(3):302-6. PubMed ID: 25582460
[TBL] [Abstract][Full Text] [Related]
26. Ischemic proximal tubular injury primes mice to endotoxin-induced TNF-alpha generation and systemic release.
Zager RA; Johnson AC; Hanson SY; Lund S
Am J Physiol Renal Physiol; 2005 Aug; 289(2):F289-97. PubMed ID: 15798091
[TBL] [Abstract][Full Text] [Related]
27. Heme oxygenase-1 mitigates ferroptosis in renal proximal tubule cells.
Adedoyin O; Boddu R; Traylor A; Lever JM; Bolisetty S; George JF; Agarwal A
Am J Physiol Renal Physiol; 2018 May; 314(5):F702-F714. PubMed ID: 28515173
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial free radical production induces lipid peroxidation during myohemoglobinuria.
Zager RA
Kidney Int; 1996 Mar; 49(3):741-51. PubMed ID: 8648915
[TBL] [Abstract][Full Text] [Related]
29. Inorganic iron effects on in vitro hypoxic proximal renal tubular cell injury.
Zager RA; Schimpf BA; Bredl CR; Gmur DJ
J Clin Invest; 1993 Feb; 91(2):702-8. PubMed ID: 8432870
[TBL] [Abstract][Full Text] [Related]
30. Parenteral iron therapy options.
Silverstein SB; Rodgers GM
Am J Hematol; 2004 May; 76(1):74-8. PubMed ID: 15114602
[TBL] [Abstract][Full Text] [Related]
31. Myoglobin toxicity in proximal human kidney cells: roles of Fe, Ca2+, H2O2, and terminal mitochondrial electron transport.
Zager RA; Burkhart K
Kidney Int; 1997 Mar; 51(3):728-38. PubMed ID: 9067905
[TBL] [Abstract][Full Text] [Related]
32. Parenteral iron therapy: a single institution's experience over a 5-year period.
Laman CA; Silverstein SB; Rodgers GM
J Natl Compr Canc Netw; 2005 Nov; 3(6):791-5. PubMed ID: 16316614
[TBL] [Abstract][Full Text] [Related]
33. Parenterial iron sucrose-induced renal preconditioning: differential ferritin heavy and light chain expression in plasma, urine, and internal organs.
Johnson AC; Gooley T; Guillem A; Keyser J; Rasmussen H; Singh B; Zager RA
Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1563-F1571. PubMed ID: 31608670
[TBL] [Abstract][Full Text] [Related]
34. An evaluation of the antioxidant protein α1-microglobulin as a renal tubular cytoprotectant.
Zager RA; Johnson AC; Frostad K
Am J Physiol Renal Physiol; 2016 Sep; 311(3):F640-51. PubMed ID: 27170684
[TBL] [Abstract][Full Text] [Related]
35. Abnormal iron deposition in renal cells in the rat with chronic angiotensin II administration.
Ishizaka N; Aizawa T; Yamazaki I; Usui S; Mori I; Kurokawa K; Tang SS; Ingelfinger JR; Ohno M; Nagai R
Lab Invest; 2002 Jan; 82(1):87-96. PubMed ID: 11796829
[TBL] [Abstract][Full Text] [Related]
36. Comparative evaluation of nephrotoxicity and management by macrophages of intravenous pharmaceutical iron formulations.
Connor JR; Zhang X; Nixon AM; Webb B; Perno JR
PLoS One; 2015; 10(5):e0125272. PubMed ID: 25973894
[TBL] [Abstract][Full Text] [Related]
37. Heme: a novel inducer of MCP-1 through HO-dependent and HO-independent mechanisms.
Kanakiriya SK; Croatt AJ; Haggard JJ; Ingelfinger JR; Tang SS; Alam J; Nath KA
Am J Physiol Renal Physiol; 2003 Mar; 284(3):F546-54. PubMed ID: 12556365
[TBL] [Abstract][Full Text] [Related]
38. Proximal tubular cytochrome c efflux: determinant, and potential marker, of mitochondrial injury.
Zager RA; Johnson AC; Hanson SY
Kidney Int; 2004 Jun; 65(6):2123-34. PubMed ID: 15149325
[TBL] [Abstract][Full Text] [Related]
39. Increased proximal tubular cholesterol content: implications for cell injury and "acquired cytoresistance".
Zager RA; Burkhart KM; Johnson AC; Sacks BM
Kidney Int; 1999 Nov; 56(5):1788-97. PubMed ID: 10571787
[TBL] [Abstract][Full Text] [Related]
40. Isoflurane alters proximal tubular cell susceptibility to toxic and hypoxic forms of attack.
Zager RA; Burkhart KM; Conrad DS
Kidney Int; 1999 Jan; 55(1):148-59. PubMed ID: 9893123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
